CytomX Therapeutics to Present at Upcoming February Conferences

On February 4, 2026 CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, reported that management will participate in the following conferences in February.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Guggenheim Emerging Outlook: Biotech Summit 2026
Date: Wednesday, February 11, 2026
Fireside Chat: 4:30 p.m. ET
Location: New York, NY

World ADC London 2026
Date: Wednesday, February 25, 2026
Presentation: 5:00 p.m. GMT
Location: London, UK

(Press release, CytomX Therapeutics, FEB 4, 2026, View Source [SID1234662466])